日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final overall survival and safety analyses of the phase III PSMAfore trial of [(177)Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

PSMAfore III期试验的最终总生存期和安全性分析,该试验比较了[(177)Lu]Lu-PSMA-617与更换雄激素受体通路抑制剂治疗既往未接受过紫杉烷类药物治疗的转移性去势抵抗性前列腺癌患者的疗效。

Fizazi, K; Chi, K N; Shore, N D; Herrmann, K; de Bono, J S; Castellano, D; Piulats, J M; Fléchon, A; Wei, X X; Mahammedi, H; Roubaud, G; Fleming, M; Haas, T; Ghebremariam, S; Kreisl, T N; Rajagopalan, S; Sartor, O; Morris, M J

Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer

Tebentafusp 是一种 T 细胞衔接剂,可促进巨噬细胞重编程,并与 IL-2 联合使用可克服癌症中的巨噬细胞免疫抑制。

Güç, Esra; Treveil, Agatha; Leach, Emma; Broomfield, Anna; Camera, Antonio; Clubley, James; Nieto Garcia, Paula; Kazachenka, Anastasiya; Khanolkar, Rahul; Del Carpio, Luis; Heyn, Holger; Hassel, Jessica C; Sacco, Joseph J; Stanhope, Sarah; Collins, Laura; Piulats, Josep M; Ranade, Koustubh; Benlahrech, Adel

Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients

转移性葡萄膜黑色素瘤患者接受替苯他福司治疗后不良事件的发生率及处理:410例患者的汇总安全性分析

Takami Sato,Marcus O Butler,Sophie Piperno-Neumann,Jessica C Hassel,Paul Nathan,Alexander N Shoushtari,Piotr Rutkowski,Richard D Carvajal,Jean-Francois Baurain,Max Schlaak,Josep M Piulats,Ryan J Sullivan,Sebastian Ochsenreither,Reinhard Dummer,John M Kirkwood,Alexandra Ikeguchi,Anthony M Joshua,Mark R Middleton,Ramakrishna Edukulla,Constance Pfeiffer,Joseph J Sacco

Social media as a source of drug safety information in the paediatric population

社交媒体作为儿科人群药物安全信息来源

Vilimelis-Piulats, Ingrid; Pérez-Ricart, Ariadna; Peligero, Maite Bosch; Calvo, Albert; Negre, Josep Maria Suñé; Juárez-Gimenez, Juan-Carlos

Comment on: "Tebentafusp Versus Nivolumab Plus Ipilimumab for Metastatic Uveal Melanoma: An E‑Value Sensitivity Analysis Assessing Effect of Unmeasured Confounders on Observational Associations"

评论:“Tebentafusp 与 Nivolumab 联合 Ipilimumab 治疗转移性葡萄膜黑色素瘤:评估未测量混杂因素对观察性关联影响的 E 值敏感性分析”

Watkins, Claire; Del Carpio, Luis; Piulats, Josep M

(177)Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

(177)Lu-PSMA-617 与更换雄激素受体通路抑制剂治疗既往未接受过紫杉烷类药物治疗的进展性转移性去势抵抗性前列腺癌患者的疗效比较 (PSMAfore):一项 3 期随机对照试验

Morris, Michael J; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S; Shore, Neal D; Chi, Kim N; Crosby, Michael; Piulats, Josep M; Fléchon, Aude; Wei, Xiao X; Mahammedi, Hakim; Roubaud, Guilhem; Študentová, Hana; Nagarajah, James; Mellado, Begoña; Montesa-Pino, Álvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

癌细胞可塑性决定了皮肤鳞状细胞癌对免疫疗法的反应

Laura Lorenzo-Sanz ,Marta Lopez-Cerda ,Victoria da Silva-Diz ,Marta H Artés ,Sandra Llop ,Rosa M Penin ,Josep Oriol Bermejo ,Eva Gonzalez-Suarez ,Manel Esteller ,Francesc Viñals ,Enrique Espinosa ,Marc Oliva ,Josep M Piulats ,Juan Martin-Liberal ,Purificación Muñoz

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

癌细胞可塑性决定了皮肤鳞状细胞癌对免疫疗法的反应

Laura Lorenzo-Sanz,Marta Lopez-Cerda,Victoria da Silva-Diz,Marta H Artés,Sandra Llop,Rosa M Penin,Josep Oriol Bermejo,Eva Gonzalez-Suarez,Manel Esteller ,Francesc Viñals ,Enrique Espinosa,Marc Oliva,Josep M Piulats,Juan Martin-Liberal,Purificación Muñoz

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma

替苯妥英钠治疗既往接受过治疗的转移性葡萄膜黑色素瘤的长期生存随访

Sacco, Joseph J; Carvajal, Richard D; Butler, Marcus O; Shoushtari, Alexander N; Hassel, Jessica C; Ikeguchi, Alexandra; Hernandez-Aya, Leonel; Nathan, Paul; Hamid, Omid; Piulats, Josep M; Rioth, Matthew; Johnson, Douglas B; Luke, Jason J; Espinosa, Enrique; Leyvraz, Serge; Collins, Laura; Holland, Chris; Sato, Takami

A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1

一项针对既往接受过大量治疗的转移性去势抵抗性前列腺癌患者的阿贝西利信号探索性研究:CYCLONE 1 研究结果

Agarwal, Neeraj; Castellano, Daniel; Alonso-Gordoa, Teresa; Arranz Arija, Jose Angel; Colomba, Emeline; Gravis, Gwenaelle; Mourey, Loic; Oudard, Stephane; Fléchon, Aude; González, Macarena; Rey, Pablo M; Schweizer, Michael T; Gallardo, Enrique; Johnston, Erica; Balar, Arjun; Haddad, Nadine; Appiah, Adams K; Nacerddine, Karim; Piulats, José M